We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Guidance for dispensing of valproate-containing medicines in the manufacturer’s original full pack, following amendments to the Human Medicines Regulations (HMRs).
VDEC responds strategically to AMR pathogens and new emerging threats (fungi, viruses, and bacteria), by determining the most appropriate research goals to combat these pathogens
VDEC’s Discovery and surveillance capabilities provide unique services across a spectrum of molecular immunology platforms.
These temporary good manufacturing practice (GMP) flexibilities will be allowed to address the current exceptional circumstances
Industry must notify the MHRA if they will not be using these flexibilities
Information on how to request assistance from NSDR.
Canada and UK Trade Continuity Agreement enters into force
Guidance for specialists for initiation of valproate in female patients and for annual review and pregnancy testing to support adherence to pregnancy prevention requirements during the pandemic.
Guidance and advice for community pharmacies in England providing services to people who use drugs and alcohol.
Advice against the use of homeopathic remedies for the prevention or treatment of malaria.
Guidance on how to make reasonable adjustments to help support people with learning disabilities in using pharmacy services.
Information on medical facilities available in Timor-Leste
This is a work sharing model for the co-ordinated assessment of a generic application that has been filed with multiple Access Consortium agencies.
Guidance for organisations involved in any aspect of the pharmaceutical lifecycle or GLP studies regulated by MHRA, covering the approval of paper documents when working from home
From discovery to real-world impact, VDEC equips scientists with the expertise and facilities to navigate each step in the development of vaccines and therapeutics.
Guidance on measures in place until the Windsor Framework takes effect on 1 January 2025.
Submitting annual reports on sales of electronic cigarettes and refill containers.
Guidance for hospital blood banks on issuing blood components electronically in line with best practice.
Outlines the aim, scope and definitions of the medical technology innovation classification framework.
Notification Fees for Great Britain and Northern Ireland
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).